Mercurius Psychiatry

Mercurius Psychiatry in Hancock, New Hampshire is an FDA-certified Spravato provider offering esketamine for treatment-resistant depression and certain cases of major depressive disorder. Unlike traditional antidepressants that work gradually through serotonin pathways, Spravato acts on NMDA receptors to influence glutamate activity in the brain, an area linked to mood regulation, neuroplasticity, and emotional processing.

Spravato is delivered on-site and self-administered under medical supervision, with dosing that follows strict clinical protocols and a required monitoring period after each session. Treatment begins with a comprehensive psychiatric evaluation to determine clinical appropriateness, and ongoing psychiatric oversight is built into care.

Spravato may be appropriate for patients who have tried multiple antidepressants without adequate relief or who experience persistent depression despite consistent treatment. The practice emphasizes patient education and structured, supervised care, and proudly serves fellow veterans.